Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6


Characterization of Asymptomatic Bacteriuria Escherichia coli Isolates in Search of Alternative Strains for Efficient Bacterial Interference against Uropathogens.

Stork C, Kovács B, Rózsai B, Putze J, Kiel M, Dorn Á, Kovács J, Melegh S, Leimbach A, Kovács T, Schneider G, Kerényi M, Emödy L, Dobrindt U.

Front Microbiol. 2018 Feb 14;9:214. doi: 10.3389/fmicb.2018.00214. eCollection 2018.


Gaining Access to Bacteria through (Reversible) Control of Lipophilicity.

Galstyan A, Putze J, Dobrindt U.

Chemistry. 2018 Jan 24;24(5):1178-1186. doi: 10.1002/chem.201704562. Epub 2017 Dec 19.


Uropathogenic E. coli Exploit CEA to Promote Colonization of the Urogenital Tract Mucosa.

Muenzner P, Kengmo Tchoupa A, Klauser B, Brunner T, Putze J, Dobrindt U, Hauck CR.

PLoS Pathog. 2016 May 12;12(5):e1005608. doi: 10.1371/journal.ppat.1005608. eCollection 2016 May.


Characterization of urinary tract infection-associated Shiga toxin-producing Escherichia coli.

Toval F, Schiller R, Meisen I, Putze J, Kouzel IU, Zhang W, Karch H, Bielaszewska M, Mormann M, Müthing J, Dobrindt U.

Infect Immun. 2014 Nov;82(11):4631-42. doi: 10.1128/IAI.01701-14. Epub 2014 Aug 25.


Bioengineered 2'-fucosyllactose and 3-fucosyllactose inhibit the adhesion of Pseudomonas aeruginosa and enteric pathogens to human intestinal and respiratory cell lines.

Weichert S, Jennewein S, Hüfner E, Weiss C, Borkowski J, Putze J, Schroten H.

Nutr Res. 2013 Oct;33(10):831-8. doi: 10.1016/j.nutres.2013.07.009. Epub 2013 Aug 13.


Genetic structure and distribution of the colibactin genomic island among members of the family Enterobacteriaceae.

Putze J, Hennequin C, Nougayrède JP, Zhang W, Homburg S, Karch H, Bringer MA, Fayolle C, Carniel E, Rabsch W, Oelschlaeger TA, Oswald E, Forestier C, Hacker J, Dobrindt U.

Infect Immun. 2009 Nov;77(11):4696-703. doi: 10.1128/IAI.00522-09. Epub 2009 Aug 31.

Supplemental Content

Support Center